Interpreting Microbial Biosynthesis in the Genomic Age: Biological and Practical Considerations

Area of Science:

• Genomics
• Natural Product Biosynthesis
• Drug Discovery

Background:

• Genome mining is a powerful tool for identifying natural products and drug leads.
• Challenges exist in analyzing biosynthetic gene clusters (BGCs) from genomic and metagenomic data, especially for symbiotic and uncultured organisms.
• Current technologies and computational methods have limitations in BGC assembly and product prediction.

Purpose of the Study:

• To review and address limitations in genome mining for natural product biosynthesis and drug discovery.
• To explore strategies for overcoming challenges in studying symbiotic, uncultured systems, and BGC assembly.
• To investigate the impact of sequencing parameters on the recovery and contiguity of large, repetitive BGCs.

Main Methods:

• Review of existing literature on genome mining challenges and solutions.
• Simulation of Illumina and PacBio sequencing data for the *Salinispora tropica* genome.
• Focus on the assembly of the salinilactam (slm) BGC to assess sequencing parameter effects.

Main Results:

• Identified key biological and practical problems complicating biosynthetic analysis in genomic projects.
• Proposed computational and experimental strategies to overcome technological limitations.
• Demonstrated how sequencing parameters influence the assembly of large and repetitive BGCs, using the *slm* BGC as a case study.

Conclusions:

• Genome mining is a vital but imperfect tool requiring advanced strategies for complex biological systems.
• Overcoming challenges in BGC assembly and product prediction is crucial for unlocking the full potential of natural product discovery.
• Understanding sequencing parameter effects is essential for optimizing genome assembly of challenging BGCs.